Coagulation and Hemostasis Testing to Boost D-Dimer Testing Market to USD 1.8 Billion by 2020

The global D-dimer testing market is estimated to reach USD 1.8 Billion in 2020, growing at a CAGR of 2.4% from 2016 to 2020, according to a new market research report D-Dimer Testing Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the D-Dimer Testing Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/d-dimer-testing-market/

The global D-dimer testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

D-dimer is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. D-dimer concentration may be determined by a blood test to help diagnose thrombosis in patients with suspected thrombotic disorders. It is mostly used to exclude thromboembolic disease and to diagnose blood disorder disseminated intravascular coagulation.

The global D-dimer testing market segmentation is based on testing methods (Clinical Chemistry Analyzers, Coagulation Analyzers, Laboratory Testing, Point-of-care Testing), and its applications (Deep Vein Thrombosis (DVT), Disseminated Intravascular Coagulation (DIC), Pulmonary Embolism (PE)). The global D-dimer testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global D-dimer testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Testing Method
1.1. Clinical Chemistry Analyzers
1.2. Coagulation Analyzers
1.3. Laboratory Testing
1.4. Point-of-care Testing

2. Application
2.1. Deep Vein Thrombosis (DVT)
2.2. Disseminated Intravascular Coagulation (DIC)
2.3. Pulmonary Embolism (PE)

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. Alere, Inc.
4.3. Beckman Coulter, Inc.
4.4. Bio/Data Corporation
4.5. Becton, Dickinson and Company
4.6. Corgenix Medical Corporation
4.7. F. Hoffmann-La Roche Ltd.
4.8. Helena Biosciences
4.9. Sysmex Corporation
4.10. Siemens Healthcare
4.11. Thermo Fisher Scientific, Inc.
4.12. Trinity Biotech plc

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.